Treatment with direct-acting antiviral agents of hepatitis C virus infection in injecting drug users: A prospective study

Clicks: 324
ID: 269409
2017
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
In this prospective study, we evaluated the effectiveness and tolerability of novel therapies against hepatitis C virus (HCV) in a cohort of PWID enrolled at our centre from April 2015 to July 2016. In this analysis, a total of 174 patients were included: eleven (6.3%) were treated with pegylated in …
Reference Key
l2017journaltreatment Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Boglione L;Mornese Pinna S;De Nicolò A;Cusato J;Cariti G;Di Perri G;D'Avolio A;;
Journal journal of viral hepatitis
Year 2017
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/28345206
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine prognosis treatment outcome adult female male aged middle aged Comorbidity Prospective Studies risk factors Genotype drug therapy combination odds ratio hepatitis c / transmission antiviral agents / therapeutic use* roc curve viral load antiviral agents / pharmacology hepacivirus / genetics Elasticity Imaging Techniques Liver Cirrhosis / pathology hepatitis c / drug therapy* hepatitis c / complications pmid:28345206 doi:10.1111/jvh.12711 l boglione s mornese pinna a d'avolio drug users* hepacivirus / drug effects* hepatitis c / virology* liver cirrhosis / diagnostic imaging liver cirrhosis / etiology

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.